We are developing a minimally invasive, catheter-based technology for nerve ablation.
Corveus Medical develops a minimally-invasive, catheter-based neuromodulation device to treat moderate heart failure. Its system provides a new treatment option by deactivating a nerve that is a root cause of disease progression. The company targets medical institutions, including hospitals and cardiology clinics, that manage heart failure patients.
$1M
3
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos